Open access peer-reviewed chapter

New Advances in Cardiac Magnetic Resonance Imaging of Congenital Heart Disease

Written By

Karima Hami

Submitted: 19 July 2023 Reviewed: 08 September 2023 Published: 18 October 2023

DOI: 10.5772/intechopen.113148

From the Edited Volume

New Advances in Magnetic Resonance Imaging

Edited by Denis Larrivee

Chapter metrics overview

40 Chapter Downloads

View Full Metrics

Abstract

Cardiac magnetic resonance (CMR) is an indispensable second-line tool, next to CT (computed tomography), in the evaluation and follow-up of congenital heart disease in adults and children, as a complement to echocardiography, without the inconvenience of X-rays. This imaging requires a long examination time and good cooperation from the patient to achieve good apnea, or the use of general anesthesia in children under 8 years of age. In this chapter, we summarize the recent advances in CMR sequences, notably the four-dimensional (4D) flow, in software and hardware technologies that allow a wider use, thanks to the simplification of the examination protocols and the decrease of the acquisition time.

Keywords

  • 4D flow
  • cardiovascular magnetic resonance
  • cardiac heart diseases
  • 3D printing
  • invasive CMR

1. Introduction

Significant improvements in the diagnosis and management of patients with congenital heart disease (CHD) have led to increased number of patients surviving to adulthood [1]. These patients require lifelong noninvasive follow-up to detect long-term complications [2, 3].

Since 2020, the ACC/AH and the ESC published [4] the new guidelines for the management of adult CHD [5].

CMR is the only imaging modality offering in a single time an excellent anatomical and functional information of the heart [6, 7]. Long follow-up with repetitive CMR imaging is reasonable for its high reproducibility and safety compared to CT and catheterization, in the young population.

This imaging requires a long examination time and good cooperation from the patient to achieve good apnea, or the use of general anesthesia in young children. The use of advanced CMR sequences as such a 4D flow is a good option for improving this limitation.

Novel emerging techniques especially advanced flow evaluation and reduced acquisition and post-processing times [8] are a major step forward in the evaluation of CHD with flow perturbations [9].

Advertisement

2. 4D flow

4D flow CMR refers to phase-contrast CMR with flow-encoding in all three spatial directions, in typical transverse, sagittal, and coronal planes and resolved to the three dimensions of space and the dimension of time along the cardiac cycle. It allows a velocity assessment in the whole heart and great vessels [10] with prospective or retrospective electrocardiogram (ECG) gating. The images obtained are displayed in a colored representation of the flow patterns.

The 4D flow enables a flow analysis in any vessel section in a single acquisition, which is especially relevant in complex CHD.

4D flow CMR requires a reliable ECG with detectable R-wave. To cover the entire aorta, it is important that the coils are positioned high enough to explore certain aortic pathologies. The scans can be relatively long and it is important to inform the patient before.

4D flow CMR employs spoiled gradient echo sequences with short TR for rapid imaging with the generation of PC angiograms without the need for an external contrast agent. According to the 4D flow cardiovascular magnetic resonance consensus statement 2023, the recommended spatial resolution in adult vessels is 2.5–3 mm3, 2–2.5 mm3 in pediatric vessels, and 30–50 ms for temporal resolution. A flip angle of 7° is advised if non-contrast acquisition [11].

The advantage of 4D flow CMR is the retrospective analysis of the blood flow through any planes of interest across the 3D volume.

Moreover, the analysis of advanced hemodynamic parameters as kinetic energy (KE) and wall shear stress (WSS) has become possible [12, 13].

4d flow allows precise assessment in a variety of clinical situations, including evaluation of the QP/QS ratio, collateral flow, and valve regurgitation.

Retrospective cardiac gating is preferred, to analyze the flow in systole and diastole.

Respiratory gating is used to avoid motion artifacts; respiratory motion compensation is a good alternative if it is available.

As with 2D, 4D flow requires a close value of real peak velocity to avoid aliasing. A VENC of 120–150 cm/s is sufficient in the absence of stenosis; otherwise it should be increased to the peak velocity expected by other methods, such as echocardiography, and using post-processing tools with anti-aliasing correction should be considered.

  • Resolution: Acquired voxel size according to JCMR consensus document [11] for intracardiac flow is 3 mm or less. In small children, higher spatial resolution is recommended, because of the smaller FOV (field of view).

Advertisement

3. Application

3.1 Fontan repair

The Fontan operation is the last stage in the palliative treatment in univentricular heart [14].

The main goal of CMR is the assessment of the ventricle function, possible valvular regurgitation, the patency of the Fontan pathway, and the presence of collateral flow [15].

Various manifestations can occur such as protein-losing enteropathy, plastic bronchitis, interstitial pulmonary edema, pleuro-pericardial effusion, and ascites. MR is able to characterize lymphatic perfusion abnormalities using static and dynamic sequences, which will not be detailed in this chapter.

Aortic forward flow should be equal to total systemic venous return and to total pulmonary venous return. The divergence in flows indicates the presence of regurgitant lesions, patent fenestration, or significant systemic-to-collateral [16].

Late gadolinium enhancement (LGE) imaging is indicated in cases of recent degradation in cardiac function, suspicion of thrombus formation, or new onset of complex arrhythmias to detect the presence and extension of myocardial fibrosis. Contrast-enhanced (CE-MRA) in the venous phase allows the assessment of the permeability of the Fontan circuit. Moreover, 4D flow imaging allows the quantification of any obstruction based on distribution patterns of caval or pulmonary artery flows (Figure 1) [16].

Figure 1.

4D flow MRI in a total cavo-pulmonary connection with flow distribution 70% into the RPA and 30% in LPA. RPA: Right pulmonary artery, LPA: Left pulmonary artery.

Advertisement

4. Tetralogy of Fallot (TOF)

An accurate assessment of pulmonary valve regurgitation (PVR) is essential prior to pulmonary revalvulation (PR). This assessment is better performed using 4D flow CMR because of the possibility to correct for through-plane motion of the valve and flow angulation. Advanced flow parameters such as ventricular kinetic energy (KE) represent a novel tool to assess cardiac function; KE represents the amount of energy present in the blood flow due to movement and is considered a good marker of ventricular efficiency; it is calculated using the following equation: KE = ½mv2 where m represents the mass (the voxel volume multiplied by the density of blood) and v represents the velocity of each voxel, determined from the 4D flow. Jeong found that the KE was abnormal in TOF patients compared to in healthy controls [17].

According to the current CMR criteria, a large percentage of patients continue to experience symptoms of the classic complications observed in patients not undergoing PR, such us ventricular arrhythmias and heart failure [18].

4D flow provides a more accurate assessment of PV regurgitant flow, which may lead to better timing of revalvulation.

Several studies show that turbulent kinetic energy in the right ventricle was higher in patients with TOF than in healthy controls, mainly in the RVOT [17, 19, 20].

Jeong demonstrated that KE is an earlier indicator of cardiac dysfunction than classic parameters such us EDVI, ESVI, and EF.

Furthermore, patients with TOF may have pulmonary valve or branch stenosis. Consequently, analysis of PA flow based on 2D PC CMR plane is prone to error. Geiger and Francois [21] found that TOF patients present helical flow patterns in the pulmonary arteries [22].

These findings have been reported by Hu et al. [23]. They found that vortices were predominantly present in the main PA and helical flow patterns were predominantly present in the right PA, which was associated with systolic energy loss in the right PA and increased RV dimensions, suggesting impaired ventricular–arterial coupling.

Advertisement

5. Aortic diseases

In the aorta, aortic flow was assessed in all three segments, on the ascending, transverse, and descending aorta, in a plane perpendicular to the aortic axis.

The advantage of the 4D flow is that the plans can be placed after the acquisition.

Vorticity and helicity are two parameters that provide information about the rotational movement of blood flow.

Vorticity describes the rotation of a fluid particle around the same axis as well as around its own axis, which describes a curved movement.

Helicity is determined from vorticity and the principal component of flow velocity, which determines the direction of flow.

In aorta, the flow has a helical pattern at the end of systole, in the upper aortic arch as has been described by Kilner [24]; (Figure 2) it allows the preservation of laminar flow in the aortic arch. In aortic pathological conditions such as aneurysms, aortic bicuspidi, coarctation, or dissection, rotational flow is abnormal.

Figure 2.

4D flow CMR of the normal aorta showing the direction of flow in all three phases of systole (early, peak, and end systole).

Advertisement

6. Three-dimensional printing and virtual reality

Three-dimensional (3D) printing technology has become an attractive tool for creating patient-specific anatomical models (Figure 3). Its role in clinical decision and patient management in complex CHD is increasing.

Figure 3.

3D-printed models of transposition of the great arteries and arterial switch operation. Ao, aorta; SVC, superior vena cava; PT, pulmonary trunk; LV, left ventricle; RA, right atrium; RV, right ventricle.

Numerous studies have demonstrated superior advantages of 3D-printed models over the traditional 2D and 3D image reconstructions, enhancing the perception of distances and spatial configuration of the complex cardiac morphology and therefore facilitating the surgical planning [25, 26, 27].

A multicenter study [28] showed that the use of 3D-printed heart CHD models enabled surgical decisions to be modified in around 50% of cases.

In a similar way, other studies have confirmed the usefulness of 3D-printed cardiac models to guide surgical procedures in patients with CHD [20, 29, 30, 31].

Gomez-Ciriza et al. [32] reported their experience of 7 years in which 3D-printed heart models were able tomodify the surgical decision in 48% of cases.

However, the large application of 3D printing technology in pediatric cardiology practice is still limited by some barriers.

Geographic location: A recent international survey [33] has found that the ability to access 3D printing technology differs from region to region.

The cost of printing materials is another factor that limits its application in many practices, especially soft and elastic materials (high-cost 3D-printed models) with tissue properties similar to normal cardiovascular tissues.

Another limitation of this model is the long time required from image reconstruction to printing and cleaning of the models.

If 3D printing is unavailable, virtual reality (VR) could be a promising technique in clinical application and medical education for CHD. Raimondil and colleagues [34] noticed that the median time to elaborate VR models was only 5 min, which is interesting compared to 3D printing models, which required a long time (8 hours).

Advertisement

7. Interventional CMR

Invasive cardiovascular magnetic resonance imaging (CMR) of cardiac catheterization is a better alternative to fluoroscopy, which has been the gold standard in the assessment of patients with congenital heart disease (CHD). It provides real-time anatomical visualization of the cardiovascular structures [35, 36, 37] and the guidance for hemodynamic data without the radiation exposure. The harmful effects of repeated use of X-rays in this population have been increasingly debated in recent years. Prolonged exposure to radiation would be associated with increased risk of cancer in adult patients followed for congenital heart disease [38, 39]. Then, interventional CMR catheterization is a good alternative without ionizing radiation in children, in whom a repetitive hemodynamic assessment would be necessary.

Conditioned catheters and guidewires with gadolinium-filled balloon have been used in CMR-guided cardiac catheterization [40, 41, 42].

A few centers reported their experiences with invasive CMR [35, 43, 44, 45, 46, 47, 48] for diagnostic and interventional procedures under CMR guidance such as CoA, and Fontan fenestration test occlusion, and pulmonary vein access [49].

ICMR is currently performed in several centers [50], in patients with CHD patients before surgery or in the postoperative follow-up, for diagnostic purposes, in particular catheterization of the right heart in cases of pulmonary hypertension or a more detailed hemodynamic study in complex congenital heart disease (pre-Fontan study, or Fontan fenestration test occlusion, for example,) or for therapeutic purposes (closure of an intercavitary shunt).

The advantage of ICMR is its ability to measure cardiac output and the QP/QS ratio by phase contrast, which have proved to be more reliable than thermodilution, which can be distorted by the presence of a valve leak, or Fick’s principle, which gives an estimated rather than measured VO2 value, and at rest rather than during exercise or stress.

In addition, MRI allows ventricular and atrial volumes, EF and functional analysis, and tissue characterization.

Reddy [49] demonstrates the potential of iCMR in diagnostic right and left heart catheterization, CoA diagnosis, and Fontan fenestration occlusion hemodynamic testing.

The balloon attached to the tip of the catheter was filled with diluted gadolinium and guided using a conditioned guide toward the structures to be evaluated hemodynamically, using the real-time sequence (Figure 4).

Figure 4.

Series showing a MR-conditional guidewire (a–b solid white arrow) used to guide the gadolinium-filled balloon (dashed white arrow) for a RHC and LHC (c), Fontan fenestration test occlusion, and measure (D–G) of the pulmonary venous saturation in the LA. F: Gadolinium-filled balloon crossing a severe CoA with the assistance of an MR-conditional guidewire. Image courtesy of Surendranath R. Veeram Reddy and Yousef Arar, pediatric cardiology, Children’s medical center Dallas, 1935 Medical District Dr., Dallas, TX, 75235, USA.

Recently, use of fully insulated nitinol guidewires is feasible in low-SAR and low-field imaging [51, 52].

In the electrophysiology field, CMR allows complete delineation of the atrial anatomy and detection of fibrosis of the left atrium and intra-atrial thrombosis. CMR-guided ablations in particular, cavotricuspid isthmus (CTI) ablation by real-time iCMR guidance is increasingly performed in different centers with similar results to conventional fluoroscopy-guided ablation [53].

Advertisement

8. Conclusion

The new techniques developed over the last decade in cardiac MRI of CHD are promising, offering reduced acquisition and post-processing times while exploring multiple flows in the same examination, thanks to 4D flow, radiation-free diagnostic and therapeutic procedures with ICMR, and accurate anatomical description elaborated by 3D printing in complex CHD. These new tools are currently used in only a few centers and should be accessible in the coming years to the various magnetic resonance imaging centers.

References

  1. 1. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population. Circulation. 2007;115:163
  2. 2. Bhatt AB, Foster E, Kuehl K, et al. Congenital heart disease in the older adult: A scientific statement from the American Heart Association. Circulation. 2015;131(1884-1931):5
  3. 3. Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the Management of Adults with Congenital Heart Disease: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Journal of the American College of Cardiology. 2019;73:1494-1563
  4. 4. Sachdeva R, Valente AM, Armstrong AK, et al. ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 appropriate use criteria for multimodality imaging during the follow-up care of patients with congenital heart disease. Journal of the American College of Cardiology. 2020;75:657-703
  5. 5. Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC guidelines for the management of adult congenital heart disease. European Heart Journal. 2021;42:563-645
  6. 6. Di Salvo G, Miller O, Babu Narayan S, et al. Imaging the adult with congenital heart disease: A multimodality imaging approach—Position paper from the EACVI. European Heart Journal - Cardiovascular Imaging. 2018;19:1077-1098
  7. 7. Sechtem U, Neubauer S, Revel D, De Roos A, Van Rossum A, Von Schulthess G, et al. The clinical role of magnetic resonance in cardiovascular disease. Task force of the European Society of Cardiology, in collaboration with the Association of European Paediatric Cardiologists. European Heart Journal. 1998;19:19-39
  8. 8. Friedrich MG. The future of cardiovascular magnetic resonance imaging. European Heart Journal. 2017;38:1698-1701
  9. 9. Carlsson M, Töger J, Kanski M, et al. Quantification and visualization of cardiovascular 4D velocity mapping accelerated with parallel imaging or k-t BLAST: Head to head comparison and validation at 1.5 T and 3 T. Journal of Cardiovascular Magnetic Resonance. 2011;13:55
  10. 10. Zhong L et al. Intracardiac 4D flow MRI in congenital heart disease: Recommendations on behalf of the ISMRM flow & motion study group. Journal of Magnetic Resonance Imaging. 2019;50(3):677-681
  11. 11. Bissell MM et al. 4D CMR Consensus statement 2023 update. Journal of Cardiovascular Magnetic Resonance. 2023;25:40
  12. 12. Kamphuis VP, Westenberg JJ, van der Palen RL, et al. Unravelling cardiovascular disease using four dimensional flow cardiovascular magnetic resonance. The International Journal of Cardiovascular Imaging. 2017;33(1069-1081):17
  13. 13. Markl M, Wallis W, Harloff A. Reproducibility of flow and wall shear stress analysis using flow-sensitive four-dimensional MRI. Journal of Magnetic Resonance Imaging. 2011;33:988-994
  14. 14. Gewillig M. The Fontan circulation. Heart. 2005;91:839-846
  15. 15. Hauser JA, Taylor AM, Pandya B. How to image the adult patient with Fontan circulation. Circulation. Cardiovascular Imaging. 2017;10:e004273
  16. 16. Puricelli F et al. Performance of cardiac MRI in pediatric and adult patients with Fontan circulation. Radiology Cardiothoracic Imaging. 2022;4(3):e210235
  17. 17. Jeong D, Anagnostopoulos PV, Roldan Alzate A, Srinivasan S, Schiebler ML, et al. Ventricular kinetic energy may provide a novel noninvasive way to assess ventricular performance in patients with repaired tetralogy of fallot. The Journal of Thoracic and Cardiovascular Surgery. 2015;149:1339-1347
  18. 18. Bokma JP, Geva T, Sleeper LA, Babu Narayan SV, Wald R, et al. A propensity score-adjusted analysis of clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Heart. 2018;104:738-744. DOI: 10.1136/heartjnl-2017-31204
  19. 19. Sjöberg P, Bidhult S, Bock J, Heiberg E, Arheden H, et al. Disturbed left and right ventricular kinetic energy in patients with repaired tetralogy of Fallot: Pathophysiological insights using 4d-flow MRI. European Radiology. 2018;28:4066-4076
  20. 20. Fredriksson A, Trzebiatowska-Krzynska A, Dyverfeldt P, Engvall J, Ebbers T, et al. Turbulent kinetic energy in the right ventricle: Potential mr marker for risk stratification of adults with repaired tetralogy of fallot. Journal of Magnetic Resonance Imaging. 2018;47:1043-1053
  21. 21. François CJ, Srinivasan S, Schiebler ML, Reeder SB, Niespodzany E, et al. 4D cardiovascular magnetic resonance velocity mapping of alterations of right heart flow patterns and main pulmonary artery hemodynamics in tetralogy of Fallot. Journal of Cardiovascular Magnetic Resonance. 2012;14(1):16
  22. 22. Geiger J, Markl M, Jung B, Grohmann J, Stiller B, et al. 4D-mr flow analysis in patients after repair for tetralogy of Fallot. European Radiology. 2011;21:1651-1657
  23. 23. Hu L, Ouyang R, Sun A, Wang Q , Guo C, et al. Pulmonary artery hemodynamic assessment of blood flow characteristics in repaired tetralogy of Fallot patients versus healthy child volunteers. Quantitative Imaging in Medicine and Surgery. 2020;10:921-933
  24. 24. Kilner PJ, Yang GZ, Mohiaddin RH, Firmin DN, Longmore DB. Helical and retrograde secondary flow patterns in the aortic arch studied by three-directional magnetic resonance velocity mapping. Circulation. 1993;88(5 Pt 1):2235-2247
  25. 25. Lau I, Sun Z. Three-dimensional printing in congenital heart disease: A systematic review. Journal of Medical Radiation Sciences. 2018;65:226-236. DOI: 10.1002/jmrs.268
  26. 26. Bhatla P, Tretter JT, Chikkabyrappa S, Chakravarti S, Mosca RS. Surgical planning for a complex double-outlet right ventricle using 3D printing. Echocardiography. 2017;34:802-804
  27. 27. Biglino G, Milano EG, Capelli C, Wray J, Shearn AI, Caputo M, et al. Three-dimensional printing in congenital heart disease: Considerations on training and clinical implementation from a teaching session. The International Journal of Artificial Organs. 2019;42:595-599
  28. 28. Valverde I, Gomez-Ciriza G, Hussain T, Suarez-Mejias C, Velasco-Forte MN, Byrne N, et al. Three-dimensional printed models for surgical planning of complex congenital heart defects: An international multicentre study. European Journal of Cardio-Thoracic Surgery. 2017;52:1139-1148
  29. 29. Kiraly L, Shah NC, Abdullah O, Al-Ketan O, Rowshan R. Three-dimensional virtual and printed prototypes in complex congenital and pediatric cardiac surgery—A multidisciplinary team-learning experience. Biomolecules. 2021;11:1703
  30. 30. Cen J, Liufu R, Wen S, Qiu H, Liu X, Chen X, et al. Three-dimensional printing, virtual reality and mixed reality for pulmonary atresia: Early surgical outcomes evaluation. Heart, Lung & Circulation. 2020;30:296-302
  31. 31. Ghosh RM, Jolley MA, Mascio CE, Chen JM, Fuller S, Rome JJ, et al. Clinical 3D modeling to guide pediatric cardiothoracic surgery and intervention using 3D printed anatomic models, computer aided design and virtual reality. 3D Printing in Medicine. 2022;8:11
  32. 32. Gómez-Ciriza G, Gómez-Cía T, Rivas-González JA, Forte MNV, Valverde I. Affordable three-dimensional printed heart models. Frontiers in Cardiovascular Medicine. 2021;8:642011
  33. 33. Illmann CF, Hosking M, Harris KC. Utility and access to 3-dimensional printing in the context of congenital heart disease: An international physician survey study. CJC Open. 2020;2:207-213
  34. 34. Raimondi F, Vida V, Godard C, Bertelli F, Reffo E, Boddaert N, et al. Fast-track virtual reality for cardiac imaging in congenital heart disease. Journal of Cardiac Surgery. 2021;36:2598-2602
  35. 35. Razavi R, Hill DL, Keevil SF, Miquel ME, Muthurangu V, Hegde S, et al. Cardiac catheterisation guided by MRI in children and adults with congenital heart disease. Lancet. 2003;362:1877-1882
  36. 36. Brown DW, Gauvreau K, Powell AJ, Lang P, Colan SD, Del Nido PJ, et al. Cardiac magnetic resonance versus routine cardiac catheterization before bidirectional Glenn anastomosis in infants with functional single ventricle: A prospective randomized trial. Circulation. 2007;116:2718-2725
  37. 37. Brown DW, Gauvreau K, Powell AJ, Lang P, del Nido PJ, Odegard KC, et al. Cardiac magnetic resonance versus routine cardiac catheterization before bidirectional Glenn anastomosis: Long-term follow-up of a prospective randomized trial. The Journal of Thoracic and Cardiovascular Surgery. 2013;146:1172-1178
  38. 38. Cohen S, Liu M, Gurvitz M, Guo L, Therrien J, Laprise C, et al. Exposure to low-dose ionizing radiation from cardiac procedures and malignancy risk in adults with congenital heart disease. Circulation. 2018;137:1334-1345
  39. 39. Roguin A, Goldstein J, Bar O, Goldstein JA. Brain and neck tumors among physicians performing interventional procedures. The American Journal of Cardiology. 2013;111:1368-1372
  40. 40. Del Cerro MJ, Moledina S, Haworth SG, Ivy D, Al Dabbagh M, Banjar H, et al. Cardiac catheterization in children with pulmonary hypertensive vascular disease: Consensus statement from the pulmonary vascular research institute, pediatric and congenital heart disease task forces. Pulmonary Circulation. 2016;6(1):118-125
  41. 41. Schmitt B, Steendijk P, Ovroutski S, Lunze K, Rahmanzadeh P, Maarouf N, et al. Pulmonary vascular resistance, collateral flow, and ventricular function in patients with a Fontan circulation at rest and during dobutamine stress. Circulation. Cardiovascular Imaging. 2010;3:623-631
  42. 42. Schmitt B, Steendijk P, Lunze K, Ovroutski S, Falkenberg J, Rahmanzadeh P, et al. Integrated assessment of diastolic and systolic ventricular function using diagnostic cardiac magnetic resonance catheterization: Validation in pigs and application in a clinical pilot study. JACC: Cardiovascular Imaging. 2009;2:1271-1281
  43. 43. Ratnayaka K, Faranesh AZ, Hansen MS, Stine AM, Halabi M, Barbash IM, et al. Real-time MRI-guided right heart catheterization in adults using passive catheters. European Heart Journal. 2013;34:380-389
  44. 44. Pushparajah K, Tzifa A, Bell A, Wong JK, Hussain T, Valverde I, et al. Cardiovascular magnetic resonance catheterization derived pulmonary vascular resistance and medium-term outcomes in congenital heart disease. Journal of Cardiovascular Magnetic Resonance. 2015;17:28
  45. 45. Pushparajah K, Tzifa A, Razavi R. Cardiac MRI catheterization: A 10-year single institution experience and review. Interventional Cardiology (London). 2014;6:335-346
  46. 46. Rogers T, Ratnayaka K, Lederman RJ. MRI catheterization in cardiopulmonary disease. Chest. 2014;145:30-36
  47. 47. Tzifa A, Krombach GA, Kramer N, Kruger S, Schutte A, von Walter M, et al. Magnetic resonance-guided cardiac interventions using magnetic resonance-compatible devices: A preclinical study and first-in-man congenital interventions. Circulation. Cardiovascular Interventions. 2010;3:585-592
  48. 48. Tzifa A, Schaeffter T, Razavi R. MR imaging-guided cardiovascular interventions in young children. Magnetic Resonance Imaging Clinics of North America. 2012;20:117-128
  49. 49. Surendranath R, Reddy V. Invasive cardiovascular magnetic resonance (iCMR) for diagnostic right and left heart catheterization using an MR-conditional guidewire and passive visualization in congenital heart disease. Journal of Cardiovascular Magnetic Resonance. 2020;22:20
  50. 50. Ratnayaka K, Kanter JP, Faranesh AZ, Grant EK, Olivieri LJ, Cross RR, et al. Radiation-free CMR diagnostic heart catheterization in children. Journal of Cardiovascular Magnetic Resonance. 2017;19(1):65
  51. 51. Campbell-Washburn AE, Rogers T, Stine AM, Khan JM, Ramasawmy R, Schenke WH, et al. Right heart catheterization using metallic guidewires and low SAR cardiovascular magnetic resonance fluoroscopy at 1.5 tesla: First in human experience. Journal of Cardiovascular Magnetic Resonance. 2018;20(1):41
  52. 52. Campbell-Washburn AE, Ramasawmy R, Restivo MC, Bhattacharya I, Basar B, Herzka DA, et al. Opportunities in interventional and diagnostic imaging by using high-performance low-field-strength MRI. Radiology. 2019;293(2):384-393
  53. 53. Rier SC, Vreemann S, Nijhof WH, van Driel V, van der Bilt IAC. Interventional cardiac magnetic resonance imaging: Current applications, technology readiness level, and future perspectives. Therapeutic Advances in Cardiovascular Disease. 2022;16:17539447221119624

Written By

Karima Hami

Submitted: 19 July 2023 Reviewed: 08 September 2023 Published: 18 October 2023